You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for Patent: 9,604,901

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,604,901 protect, and when does it expire?

Patent 9,604,901 protects REMODULIN, TYVASO DPI, TYVASO, and ORENITRAM, and is included in five NDAs.

This patent has fifteen patent family members in seven countries.

Summary for Patent: 9,604,901

Title:	Process to prepare treprostinil, the active ingredient in Remodulin.RTM.
Abstract:	This present invention relates to an improved process to prepare prostacyclin derivatives. One embodiment provides for an improved process to convert benzindene triol to treprostinil via salts of treprostinil and to purify treprostinil.
Inventor(s):	Batra; Hitesh (Herndon, VA), Tuladhar; Sudersan M. (Silver Spring, MD), Penmasta; Raju (Herndon, VA), Walsh; David A. (Palmyra, VA)
Assignee:	United Therapeutics Corporation (Silver Spring, MD)
Application Number:	14/754,932
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,604,901
Patent Claim Types: see list of patent claims	Use; Formulation; Compound;

Drugs Protected by US Patent 9,604,901

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-006	Sep 28, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-007	Sep 28, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-008	Sep 28, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-001	May 21, 2002	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-002	May 21, 2002	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-003	May 21, 2002	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-004	May 21, 2002	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y	Y		⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,604,901

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2710205	⤷ Sign Up
China	101903324	⤷ Sign Up
China	103274926	⤷ Sign Up
European Patent Office	2252570	⤷ Sign Up
European Patent Office	3287434	⤷ Sign Up
Spain	2630407	⤷ Sign Up
Japan	2011506599	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.